The companies completed the merger earlier this month after working as partner firms since 2020. Both companies are focused on the development and production of bone-graft products.
Since 2020, the companies have worked together on the development of Isto’s SPARC integrative bone matrix, which stemmed from Advanced Biologics’ OsseoGen tissue processing method.